The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical …
Poor adherence to the investigational product can bring even the most carefully planned clinical trial to its knees. It is time to accept that traditional …
CEOs in the clinical research industry have the opportunity this week to positively impact the future of the industry in the UK by providing letters …
Intelligent data management software offer will enable MedTech start-ups to bring new devices to market faster in compliance with toughening EU medical regulations Acknowledging the …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
